Security key
137404109
Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL)
CUSIP: 137404109
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 72,977,477
- Total 13F shares
- 5,257,852
- Share change
- -112,192
- Total reported value
- $4,856,205
- Price per share
- $0.92
- Number of holders
- 19
- Value change
- -$147,500
- Number of buys
- 6
- Number of sells
- 7
Report period
Q3 2023
Institutions
19
Top holders
10
CADL full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Candel Therapeutics, Inc. SEC filings
Candel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 137404109
Recent filing periods:
Top shareholders of CADL - Candel Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Northpond Ventures, LLC |
13F
|
Company |
2.7%
|
1,935,215
|
$2,438,371 | — | 30 Jun 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
1,125,000
|
$1,417,500 | — | 30 Jun 2023 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
1.1%
|
811,737
|
$1,022,789 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0.62%
|
452,557
|
$570,222 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.56%
|
405,755
|
$511,251 | — | 30 Jun 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
132,595
|
$167,070 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
131,203
|
$165,315 | — | 30 Jun 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
118,612
|
$149,451 | — | 30 Jun 2023 | |
| Mariner Managed Account Solutions, LLC |
13F
|
Company |
0.14%
|
100,540
|
$126,680 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
51,823
|
$65,296 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
27,600
|
$34,776 | — | 30 Jun 2023 | |
| OneDigital Investment Advisors LLC |
13F
|
Company |
0.03%
|
25,428
|
$32,039 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
19,617
|
$24,717 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
12,800
|
$16,000 | — | 30 Jun 2023 | |
| Empirical Asset Management, LLC |
13F
|
Company |
0.02%
|
11,000
|
$13,860 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
8,262
|
$10,410 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
186
|
$234 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
104
|
$131 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
10
|
$13 | — | 30 Jun 2023 | |
| Laura K. Aguilar |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,046,940
|
$2,742,246 | — | 06 May 2022 | |
| Udi Meirav |
3/4/5
|
Director |
—
class O/S missing
|
48,822
|
$43,940 | — | 26 Jul 2021 | |
| SMITH ALAN E |
3/4/5
|
Director |
—
class O/S missing
|
32,548
|
$29,293 | — | 26 Jul 2021 | |
| Nathan Caffo |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
6,000
|
$5,400 | — | 29 Jul 2021 | |
| John J. Canepa |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
110,000
|
— | — | 28 Feb 2022 | |
| Susan B. Stewart |
3/4/5
|
Chief Regulatory Officer |
—
class O/S missing
|
20,000
|
— | — | 11 Apr 2022 |
Institutional Holders of Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL) as of Q3 2023
As of 30 Sep 2023,
Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,257,852 shares.
The largest 10 holders included
Northpond Ventures, LLC, FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, FMR LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Baystate Wealth Management LLC, BlackRock Inc., and CITADEL ADVISORS LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
19
Q3 2023 holders
19
Holder diff
0
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.